Radiographic characteristics and poor prognostic factors of interstitial lung disease (ILD) in nivolumab-treated patients with non-small cell lung cancer (NSCLC)

被引：0

作者：

Sasaki, S. ^{[1
]}

Oikado, K. ^{[2
]}

Saito, Y. ^{[3
]}

Tominaga, J. ^{[4
]}

Sata, M. ^{[5
]}

Sakai, F. ^{[6
]}

Kato, T. ^{[7
]}

Iwasawa, T. ^{[8
]}

Kenmotsu, H. ^{[9
]}

Kusumoto, M. ^{[10
]}

Baba, T. ^{[11
]}

Endo, M. ^{[12
]}

Fujiwara, Y. ^{[13
]}

Sugiura, H. ^{[14
]}

Yanagawa, N. ^{[15
]}

Ito, Y. ^{[16
]}

Sakamoto, T. ^{[16
]}

Ohe, Y. ^{[17
]}

Kuwano, K. ^{[18
]}

机构：

[1] Juntendo Univ, Urayasu Hosp, Resp Med, Chiba, Japan

[2] Canc Inst Hosp, Dept Diagnost Imaging, Tokyo, Japan

[3] Nippon Med Coll Hosp, Dept Pulm Med & Oncol, Tokyo, Japan

[4] Tohoku Univ, Sch Med, Dept Diagnost Radiol, Sendai, Miyagi, Japan

[5] Jichi Med Univ Hosp, Div Pulm Med, Shimotsuke, Tochigi, Japan

[6] Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, Hidaka, Japan

[7] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan

[8] Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Yokohama, Kanagawa, Japan

[9] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan

[10] Natl Canc Ctr, Dept Diagnost Radiol, Tokyo, Japan

[11] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan

[12] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka, Japan

[13] Mitsui Mem Hosp, Dept Resp Med, Tokyo, Japan

[14] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan

[15] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Radiol, Tokyo, Japan

[16] Ono Pharmaceut Co Ltd, Pharmacovigilance Div, Osaka, Japan

[17] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[18] Jikei Univ, Sch Med, Dept Internal Med, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1299P

引用

页数：2

共 50 条

[1] Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer
Saito, Yoshinobu
Sasaki, Shinichi
Oikado, Katsunori
Tominaga, Junya
Sata, Masafumi
Sakai, Fumikazu
Kato, Terufumi
Iwasawa, Tae
Kenmotsu, Hirotsugu
Kusumoto, Masahiko
Baba, Tomohisa
Endo, Masahiro
Fujiwara, Yutaka
Sugiura, Hiroaki
Yanagawa, Noriyo
Ito, Yoshihiko
Sakamoto, Takahiko
Ohe, Yuichiro
Kuwano, Kazuyoshi
CANCER SCIENCE, 2021, 112 (04) : 1495 - 1505
[2] Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancer
Sata, Masafumi
Sasaki, Shinichi
Oikado, Katsunori
Saito, Yoshinobu
Tominaga, Junya
Sakai, Fumikazu
Kato, Terufumi
Iwasawa, Tae
Kenmotsu, Hirotsugu
Kusumoto, Masahiko
Baba, Tomohisa
Endo, Masahiro
Fujiwara, Yutaka
Sugiura, Hiroaki
Yanagawa, Noriyo
Ito, Yoshihiko
Sakamoto, Takahiko
Ohe, Yuichiro
Kuwano, Kazuyoshi
CANCER SCIENCE, 2021, 112 (04) : 1506 - 1513
[3] Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung Cancer
Shiroyama, Takayuki
Suzuki, Hidekazu
Tamiya, Motohiro
Tamiya, Akihiro
Tanaka, Ayako
Okamoto, Norio
Nakahama, Kenji
Taniguchi, Yoshihiko
Isa, Shun-Ichi
Inoue, Takako
Imamura, Fumio
Atagi, Shinji
Hirashima, Tomonori
ANTICANCER RESEARCH, 2018, 38 (08) : 4723 - 4729
[4] POOR PROGNOSTIC FACTORS FOR INTERSTITIAL LUNG DISEASE (ILD)-RELATED DEATH IN JAPANESE NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS IN THE POLARSTAR STUDY
Inoue, Yoshikazu
Ando, Masahiko
Ohe, Yuichiro
Nakagawa, Kazuhiko
Yamazaki, Naoya
Arakawa, Hiroaki
Ebina, Masahito
Kuwano, Kazuyoshi
Kusumoto, Masahiko
Gemma, Akihiko
Sakai, Fumikazu
Johkoh, Takeshi
Taniguchi, Hiroyuki
Fukuda, Yuh
Seki, Akihiro
Fukuoka, Masahiro
Kudoh, Shoji
RESPIROLOGY, 2013, 18 : 41 - 41
[5] EGFR-TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non-Small Cell Lung Cancer
Oshima, Yasuo
Tanimoto, Tetsuya
Yuji, Koichiro
Tojo, Arinobu
JAMA ONCOLOGY, 2018, 4 (08) : 1112 - 1115
[6] Interstitial lung disease and wedge resection are poor prognostic factors for non-small cell lung cancer
Motono, Nozomu
Ishikawa, Masahito
Iwai, Shun
Iijima, Yoshihito
Uramoto, Hidetaka
JOURNAL OF THORACIC DISEASE, 2022, 14 (04) : 1052 - 1060
[7] Analysis of Proteomic Biomarkers for Acute Interstitial Lung Disease (ILD) in Gefitinib-Treated Japanese Non-Small Cell Lung Cancer (NSCLC) Patients
Nyberg, Fredrik
Ogiwara, Atsushi
Harbron, Chris G.
Kawakami, Takao
Komatsu, Yasuhiko
Nishimura, Toshihide
Marko-Varga, Gyorgy
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S112 - S113
[8] Interstitial Lung Disease (ILD) Associated Cancer Genesis Is Noble Predictor for Patients with Non-Small Cell Lung Cancer and ILD
Miyata, Ryo
Omasa, Mitsugu
Fujimoto, Ryo
Ishikawa, Hiroyuki
Otake, Yosuke
Aoki, Minoru
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S431 - S431
[9] Nivolumab-induced interstitial lung disease (ILD) in Japanese patients with non-small cell lung cancer: A study on risk factors for fatal outcome.
Kato, Terufumi
Sakai, Fumikazu
Baba, Tomohisa
Kusumoto, Masahiko
Kenmotsu, Hirotsugu
Sugiura, Hiroaki
Tominaga, Junya
Oikado, Katsunori
Sata, Masafumi
Endo, Masahiro
Yanagawa, Noriyo
Sasaki, Shinichi
Iwasawa, Tae
Saito, Yoshinobu
Fujiwara, Yutaka
Ohe, Yuichiro
Ito, Yoshihiko
Tahara, Yasuhiro
Kuwano, Kazuyoshi
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[10] A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Kobayashi, Haruki
Naito, Tateaki
Omori, Shota
Nakashima, Kazuhisa
Wakuda, Kazushige
Ono, Akira
Kenmotsu, Hirotsugu
Murakami, Haruyasu
Endo, Masahiro
Takahashi, Toshiaki
EUROPEAN RESPIRATORY JOURNAL, 2018, 52

← 1 2 3 4 5 →